- Home
- ACNB vs ALLO Comparison
ACNB vs ALLO Comparison
Compare ACNB & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACNB | ALLO |
|---|---|---|
| Founded | 1857 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 659.3M | 597.7M |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ACNB | ALLO |
|---|---|---|
| Price | $63.94 | $1.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 15 |
| Target Price | ★ $58.00 | $8.35 |
| AVG Volume (30 Days) | 56.8K | ★ 4.8M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | N/A | ★ 34.09 |
| EPS | ★ 2.81 | N/A |
| Revenue | ★ $191,821,000.00 | N/A |
| Revenue This Year | $13.18 | N/A |
| Revenue Next Year | $1.91 | $142,416.42 |
| P/E Ratio | $22.72 | ★ N/A |
| Revenue Growth | ★ 45.10 | N/A |
| 52 Week Low | $42.60 | $1.04 |
| 52 Week High | $67.60 | $4.46 |
Technical Indicators
Market Signals| Indicator | ACNB | ALLO |
|---|---|---|
| Relative Strength Index (RSI) | 44.83 | 36.16 |
| Support Level | $62.78 | $1.59 |
| Resistance Level | $65.62 | $1.92 |
| Average True Range (ATR) | 1.58 | 0.08 |
| MACD | -0.25 | -0.02 |
| Stochastic Oscillator | 12.86 | 12.66 |
Price Performance
Historical ComparisonAbout ACNB ACNB Corporation
ACNB Corp is the financial holding company. Through its wholly-owned subsidiaries, it provides a full range of retail and commercial financial services in Pennsylvania and Maryland through its network of community banking offices. It also provides property, casualty, health, life and disability insurance serving personal and commercial clients through offices in Westminster, Maryland, and Gettysburg, Pennsylvania and is licensed to do business. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage; and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).